Back to Search
Start Over
MindMed Provides Status Update on IND for Phase 2b Trial of LSD for the Treatment of Generalized Anxiety Disorder
- Source :
- Plus Company Updates. December 22, 2021
- Publication Year :
- 2021
-
Abstract
- NEW YORK: Mind Medicine (MindMed) Inc. has issued the following news release: Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the 'Company'), a leading biotech company developing psychedelic-inspired [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.687690756